Children with a history of both maternal immune activation and prematurity are not at increased risk of ADHD symptoms.

Epidemiology Neurodevelopment Neuroimmunology Two-hit model

Journal

European child & adolescent psychiatry
ISSN: 1435-165X
Titre abrégé: Eur Child Adolesc Psychiatry
Pays: Germany
ID NLM: 9212296

Informations de publication

Date de publication:
03 Aug 2023
Historique:
received: 04 04 2023
accepted: 31 07 2023
medline: 3 8 2023
pubmed: 3 8 2023
entrez: 3 8 2023
Statut: aheadofprint

Résumé

Maternal autoimmune diseases (AID) are risk factors for Attention Deficit Hyperactivity Disorder (ADHD). Animal studies suggest that maternal immune activation (MIA) is a disease primer for ADHD, with second environmental factor precipitating the onset of the disease. Prematurity is also a major risk factor for ADHD. In this study, we sought to explore the interaction between parental AID and prematurity on ADHD risk in a community sample. Children of AID parents born prematurely appeared at increased odds of ADHD but these two risk factors do not appear to be additive (OR 1.39 [95 CI 0.75; 2.46]). Longitudinal studies with larger numbers of participants are needed.

Identifiants

pubmed: 37535256
doi: 10.1007/s00787-023-02276-8
pii: 10.1007/s00787-023-02276-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Références

Posner J, Polanczyk GV, Sonuga-Barke E (2020) Attention-deficit hyperactivity disorder. Lancet 395:450–462. https://doi.org/10.1016/S0140-6736(19)33004-1
doi: 10.1016/S0140-6736(19)33004-1 pubmed: 31982036 pmcid: 7880081
Cabana-Domínguez J, Soler Artigas M, Arribas L et al (2022) Comprehensive analysis of omics data identifies relevant gene networks for attention-deficit/hyperactivity disorder (ADHD). Transl Psychiatry 12:409. https://doi.org/10.1038/s41398-022-02182-8
doi: 10.1038/s41398-022-02182-8 pubmed: 36153331 pmcid: 9509350
Nielsen TC, Nassar N, Shand AW et al (2021) Association of maternal autoimmune disease with attention-deficit/hyperactivity disorder in children. JAMA Pediatr 175:e205487. https://doi.org/10.1001/jamapediatrics.2020.5487
doi: 10.1001/jamapediatrics.2020.5487 pubmed: 33464287 pmcid: 7816116
Han VX, Patel S, Jones HF, Dale RC (2021) Maternal immune activation and neuroinflammation in human neurodevelopmental disorders. Nat Rev Neurol 17:564–579. https://doi.org/10.1038/s41582-021-00530-8
doi: 10.1038/s41582-021-00530-8 pubmed: 34341569
Pierrat V, Marchand-Martin L, Marret S et al (2021) Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study. BMJ 373:n741. https://doi.org/10.1136/bmj.n741
doi: 10.1136/bmj.n741 pubmed: 33910920 pmcid: 8080137
Tso WW-Y, Ho FKW, Coghill D et al (2022) Preterm postnatal complications and risk of attention-deficit/hyperactivity disorder. Dev Med Child Neurol. https://doi.org/10.1111/dmcn.15401
doi: 10.1111/dmcn.15401 pubmed: 36106586
Goldberg M, Leclerc A, Zins M (2015) Cohort profile update: the GAZEL cohort study. Int J Epidemiol 44:77–77g. https://doi.org/10.1093/ije/dyu224
doi: 10.1093/ije/dyu224 pubmed: 25422284
Mary-Krause M, Herranz Bustamante JJ, Bolze C et al (2021) Cohort profile: the TEMPO cohort study. Int J Epidemiol 50:1067–1068k. https://doi.org/10.1093/ije/dyab026
doi: 10.1093/ije/dyab026 pubmed: 34015132
Achenbach TM (2018) Achenbach system of empirically based assessment (ASEBA). In: Kreutzer J, DeLuca J, Caplan B (eds) Encyclopedia of clinical neuropsychology. Springer International Publishing, Cham, pp 1–7
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5, 5th ed. American psychiatric association, Washington
Nagin DS, Odgers CL (2010) Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol 6:109–138. https://doi.org/10.1146/annurev.clinpsy.121208.131413
doi: 10.1146/annurev.clinpsy.121208.131413 pubmed: 20192788
Jones BL, Nagin DS, Roeder K (2001) A SAS procedure based on mixture models for estimating developmental trajectories. Sociol Methods Res 29:374–393. https://doi.org/10.1177/0049124101029003005
doi: 10.1177/0049124101029003005
Janecka M, Haworth CMA, Ronald A et al (2017) Paternal age alters social development in offspring. J Am Acad Child Adolesc Psychiatry 56:383–390. https://doi.org/10.1016/j.jaac.2017.02.006
doi: 10.1016/j.jaac.2017.02.006 pubmed: 28433087 pmcid: 5409803
Min X, Li C, Yan Y (2021) Parental age and the risk of ADHD in offspring: a systematic review and meta-analysis. Int J Environ Res Public Health 18:4939. https://doi.org/10.3390/ijerph18094939
doi: 10.3390/ijerph18094939 pubmed: 34066379 pmcid: 8124990
Hegvik T-A, Chen Q, Kuja-Halkola R et al (2021) Familial co-aggregation of attention-deficit/hyperactivity disorder and autoimmune diseases: a cohort study based on Swedish population-wide registers. Int J Epidemiol. https://doi.org/10.1093/ije/dyab151
doi: 10.1093/ije/dyab151 pmcid: 9189956

Auteurs

Pierre Ellul (P)

Child and Adolescent Psychiatry Department, Robert Debré Hospital, University of Paris Cité, Paris, France.
Immunology, Immunopathology, Immunotherapy, INSERM U959, Pitié Salpétrière Hospital, Sorbonne University, Paris, France.

Solène Wallez (S)

Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, ERES, 75012, Paris, France.

Eric Acquaviva (E)

Child and Adolescent Psychiatry Department, Robert Debré Hospital, University of Paris Cité, Paris, France.

Michelle Rosenzwajg (M)

Immunology, Immunopathology, Immunotherapy, INSERM U959, Pitié Salpétrière Hospital, Sorbonne University, Paris, France.

David Klatzmann (D)

Immunology, Immunopathology, Immunotherapy, INSERM U959, Pitié Salpétrière Hospital, Sorbonne University, Paris, France.

Richard Delorme (R)

Child and Adolescent Psychiatry Department, Robert Debré Hospital, University of Paris Cité, Paris, France.
Human Genetics and Cognitive Functions Unit, Pasteur Institute Paris, Paris, France.

Maria Melchior (M)

Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, ERES, 75012, Paris, France. maria.melchior@inserm.fr.

Classifications MeSH